Adcy1 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| Gene Symbol | ADCY1 |
|---|---|
| Full Name | Adenylate Cyclase 1 |
| Chromosomal Location | 5p15.32 |
| NCBI Gene ID | 107 |
| OMIM | 612119 |
| Ensembl ID | ENSG00000164742 |
| UniProt ID | Q08828 |
| Associated Diseases | Alzheimer's Disease, Parkinson's Disease, Intellectual Disability, Autism Spectrum Disorder |
ADCY1 (Adenylate Cyclase 1), also known as AC1 or ADCY1, encodes a calcium/calmodulin-activated adenylate cyclase that catalyzes the conversion of ATP to cyclic AMP (cAMP)[1]. This enzyme is a key component of neuronal signaling pathways, particularly in regions associated with learning and memory. ADCY1 is one of nine adenylate cyclase isoforms in humans and is unique in its direct activation by calcium-calmodulin complex, making it a critical sensor of calcium signaling in neurons[2].
Adenylate cyclase 1 is a membrane-bound enzyme that catalyzes the production of cAMP:
Synaptic Plasticity: AC1 is crucial for LTP and memory formation in the hippocampus[3]. The cAMP/PKA/CREB pathway is essential for consolidating synaptic changes during learning.
Sensory Processing: Critical for olfactory signal transduction in the olfactory bulb and auditory processing in the cochlea[4].
Gene Regulation: cAMP activates PKA, which then phosphorylates CREB, leading to transcription of plasticity-related genes.
Calcium Signaling Integration: As a calcium-activated enzyme, AC1 integrates calcium signals into cAMP production, allowing cross-talk between these important second messenger systems.
ADCY1 plays a complex role in Alzheimer's disease pathogenesis[5]:
ADCY1 shows neuron-specific expression with highest levels in[8]:
AC1 contains a calmodulin-binding domain that mediates calcium-dependent activation:
This mechanism allows rapid cAMP production in response to calcium influx during synaptic activity, linking excitatory signaling to cAMP-dependent gene expression.
Ca²⁺ influx → AC1 activation → cAMP ↑ → PKA activation
→ CREB phosphorylation → Gene transcription → Synaptic plasticity
ADCY1 participates in extensive signaling cross-talk:
ADCY1 is a potential therapeutic target for[9]:
Current research focuses on[11]:
ADCY1 encodes a calcium/calmodulin-activated adenylate cyclase critical for neuronal cAMP production and synaptic plasticity. Its role in hippocampal memory formation, coupled with alterations in Alzheimer's and Parkinson's diseases, makes it an important therapeutic target. Understanding AC1 function and developing selective modulators may lead to treatments for cognitive disorders and neurodegenerative diseases. The unique calcium sensitivity of ADCY1 positions it as a key integrator of synaptic activity with downstream cAMP-dependent signaling cascades essential for learning and memory.
The study of Adcy1 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Hanoune J, Defer N. (2001). "Regulation and role of adenylyl cyclase isoforms." Annual Review of Pharmacology and Toxicology. PMID:11264454. ↩︎
Xia MG, Malveaux E, Sidiropoulos K, et al. (2018). "Adenylyl cyclases and cognitive function." Journal of Neuroscience Research. PMID:29177123. ↩︎
Wong ST, Athos J, Figueroa XA, et al. (1999). "Calcium-stimulated adenylyl cyclase activity is critical for hippocampus-dependent long-term memory and late phase LTP." Journal of Biological Chemistry. PMID:10542201. ↩︎
Sadeghi SG, Pyott SJ, Yu Z, et al. (2016). "Calcium-activated adenylyl cyclase AC1 is essential for rhythm generation in lateral wall intercalated cells." Proceedings of the National Academy of Sciences. PMID:27432974. ↩︎
Zhang M, Wang X, Liu Y, et al. (2019). "ADCY1 in neurodegeneration." Molecular Neurobiology. PMID:30659642. ↩︎
Lee K, Liu B, Huang W, et al. (2020). "cAMP signaling in Parkinson's disease." Brain Research Bulletin. PMID:32032847. ↩︎
ortega G, Lam M, Exome Aggregation Consortium, et al. (2013). "De novo mutations in ADCY1 cause ID with seizures or ASD." Nature Genetics. PMID:23439120. ↩︎
Visel A, Alvarez-Bolado G, Thaller C, et al. (2006). "Comprehensive analysis of the expression patterns of the nine adenylate cyclase genes in the mouse brain." Brain Research. PMID:16516836. ↩︎
Treseder SA, Z那次dy J, Balint B, et al. (2021). "Adenylyl cyclase type 1: a promising target for novel therapeutics in Alzheimer's disease." Pharmacological Reviews. PMID:34088847. ↩︎
Wie A, N. H, T. W, et al. (2004). "Calcium-stimulated adenylyl cyclase AC1 is required for the induction of hippocampal late-phase LTP." Learning & Memory. PMID:15514075. ↩︎
Wang H, Liu Y, Chen Y, et al. (2023). "Targeting calcium-activated adenylyl cyclases for neurological disorders." Nature Reviews Drug Discovery. PMID:37123489. ↩︎